DMX-200 Phase 2 Clinical Trial in FSGS Fully Recruited
Filed with ASX · · 2 pages · English
Story so far
Earlier from Dimerix
- DMX-200 Clinical Update
- Dimerix Signs Licence Agreement for Receptor-HIT Technology
- DMX-200 Manufacturing Update
- Appendix 4C - quarterly
- Appendix 4C and Quarterly Highlights
Later from Dimerix
- DMX-200 Phase 2 Clinical Study in DKD Completes Recruitment
- New Drug Pipeline Candidate DMX-700 & Company Update
- Dimerix Holds Pre-IND Meeting on DMX-200 With FDA
- Dimerix Completes $2.5m Placement
- DMX-200 Clinical Trial Update
Follow Dimerix into a list and get an email when it puts out news.
Follow Dimerix